Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AtaiBeckley Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ATAI
Nasdaq
2830
www.ataibeckley.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AtaiBeckley Inc.
AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating
- Jun 4th, 2026 11:38 am
Is AtaiBeckley’s BPL-003 Phase 3 Launch Altering The Investment Case For AtaiBeckley (ATAI)?
- Jun 4th, 2026 12:11 am
Assessing AtaiBeckley (ATAI) Valuation After Strong Returns And Elevated Price To Book Ratio
- Jun 3rd, 2026 8:12 pm
AtaiBeckley launches mental health patient impact grant program
- May 28th, 2026 7:57 am
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
- May 28th, 2026 7:00 am
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
- May 27th, 2026 4:00 am
AtaiBeckley (ATAI) Reports Q1 Financial Results
- May 22nd, 2026 12:43 pm
A Look At AtaiBeckley (ATAI) Valuation As Share Price Momentum And DCF Signal Differ
- May 15th, 2026 6:22 pm
AtaiBeckley clinical pipeline advances toward multiple late-stage data catalysts, Jefferies says
- May 13th, 2026 11:06 am
AtaiBeckley targets Q2 start for Phase 3 depression trial as pipeline advances
- May 12th, 2026 7:22 am
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
- May 12th, 2026 6:00 am
AtaiBeckley (ATAI) Reports Positive Phase 2a Results for Social Anxiety Treatment EMP-01
- May 9th, 2026 10:00 pm
Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform?
- May 1st, 2026 9:19 am
These 3 Psychedelic Stocks Activated After Trump's Executive Order
- Apr 27th, 2026 9:15 am
AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials
- Apr 27th, 2026 6:22 am
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
- Apr 27th, 2026 2:05 am
FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit.
- Apr 24th, 2026 2:12 pm
Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check.
- Apr 24th, 2026 9:58 am
FDA Fast-Tracks Psychedelic Drug Research Following Trump Directive; Psychedelic Drug Makers Gain
- Apr 24th, 2026 8:19 am
Atai Beckley (ATAI): The Best Penny Stock to Buy and Hold Under $5
- Apr 23rd, 2026 1:31 am
Scroll